COMBINATION CORTICOSTEROID/LONG-ACTING BRONCHODILATOR
Advair Diskus is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as a twice-daily treatment for asthma in people aged 4 and older. Advair Diskus is a combination drug composed of Fluticasone propionate and Salmeterol. Advair Diskus cannot be used as a rescue inhaler for sudden breathing problems.
Fluticasone is a glucocorticoid steroid, a drug that suppresses the immune system. Fluticasone is believed to work by reducing inflammation in the lungs, lowering the risk of bronchospasm. Salmeterol is a long-acting bronchodilator (LABA), a drug that dilates the bronchi and bronchioles in the lungs, making it easier to breathe. Salmeterol is believed to work by relaxing smooth muscles in the airways.
How do I take it?
Advair Diskus is generally taken twice daily by oral inhalation.
Advair Diskus is an inhalation powder taken using the special Diskus inhaler.
The FDA-approved label for Advair Diskus lists common side effects including headaches, upper respiratory tract infections, fungal infections in the mouth, throat irritation, bronchitis, cough, nausea, and vomiting.
Rare but serious side effects listed for Advair Diskus include increased risk for pneumonia, worsening infections, paradoxical bronchospasm (bronchospasm caused by taking medication), hypercorticism (hormonal imbalance), and asthma-related hospitalization and death.
For more details about this treatment, visit:
Advair — GSK